Intellia Therapeutics, Inc. (NTLA)
12.10
+0.75
(+6.61%)
USD |
NASDAQ |
Nov 09, 16:00
12.03
-0.07
(-0.58%)
After-Hours: 18:20
Intellia Therapeutics Gross Profit (Annual) : 51.75M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 51.75M |
| December 31, 2024 | 47.59M |
| December 31, 2023 | 27.30M |
| December 31, 2022 | 44.55M |
| December 31, 2021 | 26.16M |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | -0.003M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Twist Bioscience Corp. | 191.00M |
| Beam Therapeutics, Inc. | 117.45M |
| Prime Medicine, Inc. | -2.689M |
| 10X Genomics, Inc. | 452.45M |
| Moderna, Inc. | 861.00M |